Search research articles
Contact Us
Filters
Showing results (1-10 of 460) with videos related to
Page
of 46
Sort By:
European Journal of Internal Medicine
|
August 21, 2013
Introducing the "Internal Medicine Flashcards": call for papers
Lorenzo Dagna
International Journal of Cardiology
|
October 28, 2025
Interleukin-1 blockade in STEMI: Beyond the history of coronary artery disease
Lorenzo Dagna
Dermatologic Clinics
|
December 1, 2015
BRAF Mutations in Erdheim-Chester Disease
Corrado Campochiaro, Lorenzo Dagna
The Lancet. Respiratory Medicine
|
January 25, 2021
The right place for IL-1 inhibition in COVID-19
Giulio Cavalli, Lorenzo Dagna
European Journal of Internal Medicine
|
May 1, 2022
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle
Nicola Farina, Lorenzo Dagna
The Lancet. Rheumatology
|
August 25, 2020
The conundrum of interleukin-6 blockade in COVID-19
Corrado Campochiaro, Lorenzo Dagna
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 22, 2020
Anakinra in COVID-19-How to Interpret Elevations of Serum Liver Enzymes: Comment on the Article by Navarro-Millán et al
Giulio Cavalli, Lorenzo Dagna
European Journal of Internal Medicine
|
August 4, 2023
Immune regulators for the treatment of COVID-19: A critical appraisal after two years
Nicola Farina, Lorenzo Dagna
The Lancet. Respiratory Medicine
|
November 10, 2021
The course of action for effective anti-cytokine treatment in COVID-19
Giulio Cavalli, Lorenzo Dagna
The Lancet. Rheumatology
|
August 25, 2020
Effect of anakinra in COVID-19 - Authors' reply
Giulio Cavalli, Lorenzo Dagna
Page
of 46
Search research articles
Search
Showing results (1-10 of 460) with videos related to
Sort By:
Page
of 46
European Journal of Internal Medicine
|
August 21, 2013
Introducing the "Internal Medicine Flashcards": call for papers
Lorenzo Dagna
International Journal of Cardiology
|
October 28, 2025
Interleukin-1 blockade in STEMI: Beyond the history of coronary artery disease
Lorenzo Dagna
Dermatologic Clinics
|
December 1, 2015
BRAF Mutations in Erdheim-Chester Disease
Corrado Campochiaro, Lorenzo Dagna
The Lancet. Respiratory Medicine
|
January 25, 2021
The right place for IL-1 inhibition in COVID-19
Giulio Cavalli, Lorenzo Dagna
European Journal of Internal Medicine
|
May 1, 2022
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle
Nicola Farina, Lorenzo Dagna
The Lancet. Rheumatology
|
August 25, 2020
The conundrum of interleukin-6 blockade in COVID-19
Corrado Campochiaro, Lorenzo Dagna
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 22, 2020
Anakinra in COVID-19-How to Interpret Elevations of Serum Liver Enzymes: Comment on the Article by Navarro-Millán et al
Giulio Cavalli, Lorenzo Dagna
European Journal of Internal Medicine
|
August 4, 2023
Immune regulators for the treatment of COVID-19: A critical appraisal after two years
Nicola Farina, Lorenzo Dagna
The Lancet. Respiratory Medicine
|
November 10, 2021
The course of action for effective anti-cytokine treatment in COVID-19
Giulio Cavalli, Lorenzo Dagna
The Lancet. Rheumatology
|
August 25, 2020
Effect of anakinra in COVID-19 - Authors' reply
Giulio Cavalli, Lorenzo Dagna
Page
of 46